Browse > Article
http://dx.doi.org/10.5999/aps.2015.42.1.4

The Clinical Implications of Poly Implant Proth$\grave{e}$se Breast Implants: An Overview  

Wazir, Umar (The London Breast Institute, Princess Grace Hospital)
Kasem, Abdul (The London Breast Institute, Princess Grace Hospital)
Mokbel, Kefah (The London Breast Institute, Princess Grace Hospital)
Publication Information
Archives of Plastic Surgery / v.42, no.1, 2015 , pp. 4-10 More about this Journal
Abstract
Mammary implants marketed by Poly Implant Proth$\grave{e}$se (PIP) were found to contain industrial grade silicone and this caused heightened anxiety and extensive publicity regarding their safety in humans. These implants were used in a large number of patients worldwide for augmentation or breast reconstruction. We reviewed articles identified by searches of Medline, PubMed, Embase, and Google Scholar databases up to May 2014 using the terms: "PIP", "Poly Implant Proth$\grave{e}$se", "breast implants" and "augmentation mammoplasty" "siloxanes" or "silicone". In addition the websites of regulating bodies in Europe, USA, and Australia were searched for reports related to PIP mammary implants. PIP mammary implants are more likely to rupture than other implants and can cause adverse effects in the short to the medium term related to the symptoms of rupture such as pain, lumps in the breast and axilla and anxiety. Based on peer-reviewed published studies we have calculated an overall rupture rate of 14.5% (383/2,635) for PIP implants. However, there is no evidence that PIP implant rupture causes long-term adverse health effects in humans so far. Silicone lymphadenopathy represents a foreign body reaction and should be treated conservatively. The long-term adverse effects usually arise from inappropriate extensive surgery, such as axillary lymph node dissection or extensive resection of breast tissue due to silicone leakage.
Keywords
Prosthesis failure; Breast implants; Breast implantation; Silicone; Silicone gels;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Berry MG, Stanek JJ. PIP implant biodurability: a post-publicity update. J Plast Reconstr Aesthet Surg 2013;66:1174-81.   DOI
2 Howe E. Poly Implant Prothese (PIP) silicone breast implants: review of the actions of the MHRA and Department of Health. Internal review. London: Department of Health (DoH); 2012 May. Reference No.: 17528.
3 Keogh B. Poly Implant Prothese (PIP) breast implants: final report of the Working Group. Leeds, UK: Department of Health, NHS Medical Directorate; 2012. Report No. 17744.
4 Identification of PBT and vPvB substance: results of evaluation of PBT/vPvB properties: Octamethylcyclotetrasiloxane [Internet]. Helsinki, Finland: European Chemicals Agency (ECHA); 2012[cited 2014 May 16]. Available from: http://echa.europa.eu/documents/10162/13628/octamethyl_pbtsheet_en.pdf.
5 Maijers MC, Niessen FB. Prevalence of rupture in poly implant Prothese silicone breast implants, recalled from the European market in 2010. Plast Reconstr Surg 2012;129:1372-8.   DOI
6 Holmich LR, Friis S, Fryzek JP, et al. Incidence of silicone breast implant rupture. Arch Surg 2003;138:801-6.   DOI
7 Crouzet C, Gangloff D, Chaput B, et al. Outcome at 18 months after the recall of Poly Implant Prosthesis. Experience of a cancer center. Ann Chir Plast Esthet 2012;57:9-15.   DOI
8 Spear SL, Murphy DK; Allergan Silicone Breast Implant U.S. Core Clinical Study Group. Natrelle round silicone breast implants: core study results at 10 years. Plast Reconstr Surg 2014;133:1354-61.   DOI
9 NHS Choices. PIP breast implants-latest from the NHS [Internet]. London: NHS Choices; 2012 [cited 2014 May 16]. Available from: http://www.nhs.uk/news/2012/01January/Pages/government-review-advises-on-french-pip-breast-implants.aspx.
10 SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Scientific opinion on the Safety of Poly Implant Prothese (PIP) Silicone Breast Implants [Internet]. Brussels: European Union; 2013 [cited 2014 May 12]. Available from: http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_043.pdf.
11 Les protheses mammaires implantables PIP: etat des lieux [Internet]. Paris: ANSM; 2013 2012 [cited 2014 May 16]. Available from: http://ansm.sante.fr/content/download/ 47687/615167/version/2/file/PIP_Etat-des-lieux_v2_Avril2013.pdf.
12 Quaba O, Quaba A. PIP silicone breast implants: rupture rates based on the explantation of 676 implants in a single surgeon series. J Plast Reconstr Aesthet Surg 2013;66:1182-7.   DOI
13 Heden P, Bronz G, Elberg JJ, et al. Long-term safety and effectiveness of style 410 highly cohesive silicone breast implants. Aesthetic Plast Surg 2009;33:430-6.   DOI
14 Oulharj S, Pauchot J, Tropet Y. PIP breast implant removal: a study of 828 cases. J Plast Reconstr Aesthet Surg 2014;67:302-7.   DOI
15 Tropet Y, Oulharj S, Pauchot J. PIP breast implants: a series of 217 explants. Bull Acad Natl Med 2013;197:123-30.
16 Hammond DC, Migliori MM, Caplin DA, et al. Mentor Contour Profile Gel implants: clinical outcomes at 6 years. Plast Reconstr Surg 2012;129:1381-91.   DOI
17 Maxwell GP, Van Natta BW, Murphy DK, et al. Natrelle style 410 form-stable silicone breast implants: core study results at 6 years. Aesthet Surg J 2012;32:709-17.   DOI
18 Adams TS, Crook T, Cadier MA. A late complication following the insertion of hydrogel breast implants. J Plast Reconstr Aesthet Surg 2007;60:210-2.   DOI
19 Berry RB. Rupture of PIP breast implants. J Plast Reconstr Aesthet Surg 2007;60:967-8.
20 Maijers MC, Niessen FB. The clinical and diagnostic consequences of Poly Implant Prothese silicone breast implants, recalled from the European market in 2010. Plast Reconstr Surg 2013;131:394e-402e.   DOI
21 Aktouf A, Auquit-Auckbur I, Coquerel-Beghin D, et al. Breast augmentation by Poly Implant Protheses silicone implants: retrospective study about 99 patients. Rupture analysis and management. Ann Chir Plast Esthet 2012;57:558-66.   DOI
22 Yildirimer L, Seifalian AM, Butler PE. Surface and mechanical analysis of explanted Poly Implant Prosthese silicone breast implants. Br J Surg 2013;100:761-7.   DOI
23 Chummun S, McLean NR. Poly implant prothese (PIP) breast implants: our experience. Surgeon 2013;11:241-5.   DOI
24 Swarts E, Kop AM, Nilasaroya A, et al. Rupture of poly implant prothese silicone breast implants: an implant retrieval study. Plast Reconstr Surg 2013;131:480e-489e.   DOI
25 Barr S, Hill E, Bayat A. Current implant surface technology:an examination of their nanostructure and their influence on fibroblast alignment and biocompatibility. Eplasty 2009;9:e22.
26 Beretta G, Malacco M. Chemical and physicochemical properties of the high cohesive silicone gel from Poly Implant Prothese (PIP) breast prostheses after explantation: a preliminary, comparative analytical investigation. J Pharm Biomed Anal 2013;78-79:75-82.   DOI
27 Composition and toxicity of PIP silicone: current MHRA view [Internet]. London, UK: Medicines and Healthcare products Regulatory Agency (MHRA); 2012 [cited 2014 May 16]. Available from: http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con216972.pdf.
28 Silikonbrostimplantat av market poly implant prothese (PIP): Lakemedelsverkets riskvardering och underlag till ny rekommendation [Internet]. Upsala, Sweden: Lakemedelsverket/Medical Products Agency; 2013 [cited 2014 May 16]. Available from: http://www.lakemedelsverket.se/upload/nyheter/2013/PIP/Riskvardering-av-PIP-implantat_2013-06-24.pdf.
29 McConnell JP, Moyer TP, Nixon DE, et al. Determination of silicon in breast and capsular tissue from patients with breast implants performed by inductively coupled plasma emission spectroscopy. Comparison with tissue histology. Am J Clin Pathol 1997;107:236-46.   DOI
30 Brooke DN, Crookes MJ, Gray D, et al. Environmental risk assessment report: octamethylcyclotetrasiloxane. Bristol, UK: Environment Agency (UK); 2009. Report No. SCHO0309 BPQZ-E-P.
31 Brooke DN, Crookes MJ, Gray D, et al. Environmental risk assessment report: decamethylcyclopentasiloxane. Bristol, UK: Environment Agency (UK); 2009. Report No. SCHO 0309BPQX-E-P.
32 Brooke DN, Crookes MJ, Gray D, et al. Environmental risk assessment report: dodecamethylcyclohexasiloxane. Bristol, UK: Environment Agency (UK); 2009. Report No. SCHO 0309BPQY-E-P.
33 Breast implants with silicone based gel filling from Poly Implant Prothese Company: update of tests results. Paris, France: Agence francaise de securite sanitaire des produits de sante (AFSSAPS); 2011.
34 Update on TGA testing of PIP breast implants [Internet]. Symonston, AU: Therapeutic Goods Administration; 2011 [cited 2014 May 16]. Available from: http://www.tga.gov.au/safety/alerts-device-breast-implants-pip-130211-testing.htm.
35 Report of lymphoma associated with breast implants [Internet]. Symonston C, Australia: Therapeutic Goods Administration; 2011 [cited 2014 May 16]. Available from: http://www.tga.gov.au/safety/alerts-device-breast-implants-110127.htm.
36 Siddiqui WH, Stump DG, Plotzke KP, et al. A two-generation reproductive toxicity study of octamethylcyclotetrasiloxane (D4) in rats exposed by whole-body vapor inhalation. Reprod Toxicol 2007;23:202-15.   DOI
37 Martindale V, Menache A. The PIP scandal: an analysis of the process of quality control that failed to safeguard women from the health risks. J R Soc Med 2013;106:173-7.   DOI
38 Scientific opinion on the Safety of Poly Implant Prothese (PIP) Silicone Breast Implants (2013 update). Luxembourg: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR); 2014. Report No. 43.
39 Forster NA, Kunzi W, Giovanoli P. The reoperation cascade after breast augmentation with implants: what the patient needs to know. J Plast Reconstr Aesthet Surg 2013;66:313-22.   DOI
40 Preliminary Opinion on the safety of Poly Implant Prothese (PIP) Silicone Breast Implants. Luxembourg: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR); 2013.
41 Maijers MC, Niessen FB, Veldhuizen JF, et al. MRI screening for silicone breast implant rupture: accuracy, inter- and intraobserver variability using explantation results as reference standard. Eur Radiol 2014;24:1167-75.   DOI
42 Zambacos GJ, Molnar C, Mandrekas AD. Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts. Aesthetic Plast Surg 2013;37:278-89.   DOI
43 Flassbeck D, Pfleiderer B, Klemens P, et al. Determination of siloxanes, silicon, and platinum in tissues of women with silicone gel-filled implants. Anal Bioanal Chem 2003;375:356-62.   DOI
44 Parvizi N, Woods K. Regulation of medicines and medical devices: contrasts and similarities. Clin Med 2014;14:6-12.   DOI